Lineage Cell Therapeutics, Inc. (LCTX)
+0.020 (1.89%)
May 17, 2024, 4:00 PM EDT - Market closed

Lineage Cell Therapeutics Statistics

Total Valuation

LCTX has a market cap or net worth of $203.90 million. The enterprise value is $163.53 million.

Market Cap 203.90M
Enterprise Value 163.53M

Important Dates

The last earnings date was Thursday, May 9, 2024, after market close.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

LCTX has 188.80 million shares outstanding. The number of shares has increased by 7.51% in one year.

Shares Outstanding 188.80M
Shares Change (YoY) +7.51%
Shares Change (QoQ) +4.51%
Owned by Insiders (%) 0.43%
Owned by Institutions (%) 49.79%
Float 146.32M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 25.48
Forward PS 11.73
PB Ratio 2.82
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 20.43
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.04.

Current Ratio 2.71
Quick Ratio 2.59
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -34.20% and return on invested capital (ROIC) is -32.72%.

Return on Equity (ROE) -34.20%
Return on Assets (ROA) -22.10%
Return on Capital (ROIC) -32.72%
Revenue Per Employee $117,691
Profits Per Employee -$347,882
Employee Count 68
Asset Turnover 0.08
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -21.74% in the last 52 weeks. The beta is 1.39, so LCTX's price volatility has been higher than the market average.

Beta (1Y) 1.39
52-Week Price Change -21.74%
50-Day Moving Average 1.24
200-Day Moving Average 1.18
Relative Strength Index (RSI) 44.41
Average Volume (30 Days) 985,793

Short Selling Information

The latest short interest is 10.90 million, so 5.77% of the outstanding shares have been sold short.

Short Interest 10.90M
Short Previous Month 10.40M
Short % of Shares Out 5.77%
Short % of Float 7.45%
Short Ratio (days to cover) 11.87

Income Statement

In the last 12 months, LCTX had revenue of $8.00 million and -$23.66 million in losses. Loss per share was -$0.13.

Revenue 8.00M
Gross Profit 7.35M
Operating Income -24.75M
Pretax Income -23.66M
Net Income -23.66M
EBITDA -22.96M
EBIT -23.66M
Loss Per Share -$0.13
Full Income Statement

Balance Sheet

The company has $43.62 million in cash and $3.25 million in debt, giving a net cash position of $40.37 million or $0.21 per share.

Cash & Cash Equivalents 43.62M
Total Debt 3.25M
Net Cash 40.37M
Net Cash Per Share $0.21
Equity / Book Value 72.40M
Book Value Per Share 0.38
Working Capital 28.83M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.11 million and capital expenditures -$524,000, giving a free cash flow of -$23.63 million.

Operating Cash Flow -23.11M
Capital Expenditures -524,000
Free Cash Flow -23.63M
FCF Per Share -$0.13
Full Cash Flow Statement


Gross margin is 91.88%, with operating and profit margins of -309.28% and -295.59%.

Gross Margin 91.88%
Operating Margin -309.28%
Pretax Margin -295.59%
Profit Margin -295.59%
EBITDA Margin -286.89%
EBIT Margin -295.59%
FCF Margin -295.28%

Dividends & Yields

LCTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -7.51%
Shareholder Yield -7.51%
Earnings Yield -11.60%
FCF Yield -11.59%
Dividend Details

Analyst Forecast

The average price target for LCTX is $6.50, which is 501.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.50
Price Target Difference 501.85%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 76.47%
EPS Growth Forecast (5Y) 0.40%
Stock Forecasts

Stock Splits

The last stock split was on October 31, 1997. It was a forward split with a ratio of 3:1.

Last Split Date Oct 31, 1997
Split Type Forward
Split Ratio 3:1


LCTX has an Altman Z-Score of -2.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.12
Piotroski F-Score 2